Archive for: prescription drugs

  • ORIGINAL ANALYSIS

  • PDF DOWNLOAD

  • EXTERNAL LINK

  • POST

Insight: original analysis

McDermottPlus Healthcare Preview: October 28, 2019

A House Vote on Prescription Drug Pricing Reforms Slips as We Approach a One Week Recess in the House.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Healthcare Preview: October 21, 2019

Administrator Verma is testifying, and the debate on prescription drug pricing reforms continues.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Healthcare Preview: October 14, 2019

Congress is back for a six week stretch. And the Healthcare Preview podcast is now available on Sound Cloud.

ORIGINAL ANALYSIS

Insight: original analysis

Overlapping Provisions in Major Healthcare Bills 2019

Lawmakers came with big ambitions for 2019, but we are headed into 2020 with two major health policies left on life support and many healthcare programs nearing expiration.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Health Care Preview: September 30, 2019

Congress is out on a two recess, but the effects of the impeachment inquiry will have long lasting impacts.  

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: September 20, 2019

This Week’s Dose: Speaker Pelosi released her long-awaited drug pricing bill, and the House Energy and Commerce Committee questioned drug companies’ financial motivations during a hearing this week.

ORIGINAL ANALYSIS

Insight: original analysis

The Overlap of Drug Pricing Proposals

On September 19, 2019, the Speaker of the US House of Representatives released a proposal to contain federal and individual spending on prescription drugs, joining Administration and Senate efforts to address prescription drug pricing. This article contemplates the likelihood of a drug pricing package and how it could come together.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: July 26, 2019

This Week’s Dose: The Senate Finance Committee finally released its drug pricing package and moved quickly to a markup. The bill passed out of committee, but work will continue before the full Senate votes. We’ll be watching closely as things develop.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: June 21, 2019

This Week’s Dose: Three weeks down, one week to go in this work period. The Senate Health, Education, Labor and Pensions (HELP) Committee is moving forward with its cost containment legislation, and the House passed the first batch of health care extenders.

ORIGINAL ANALYSIS

Insight: original analysis

CMS Releases Final Rule Aimed at Lowering Drug Prices and Reducing Out-of-Pocket Spending

Since mid-2018, the Centers for Medicare and Medicaid Services has been implementing sections of the American Patients First Blueprint, President Trump’s plan to lower drug prices and reduce patient out-of-pocket spending.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: May 3, 2019

This Week’s Dose: Lots of activity surrounding single-payer this week with a hearing, the introduction of two Medicare expansion bills and a report from the Congressional Budget Office (CBO). Hearings and markups of drug pricing bills continue as well. This legislative session is off to a busy start.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: April 12, 2019

This Week’s Dose: Drug pricing continues to be the focus in Congress with multiple hearings and markups on the subject. So far, lowering drug prices remains a rare area of consensus among lawmakers.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: April 5, 2019

This Week’s Dose: Health care continues to dominate much of the attention on Capitol Hill. Lots of hearings. New coverage expansion legislation. And more state action on Medicaid.

ORIGINAL ANALYSIS

Insight: original analysis

Analyzing the President’s FY 2020 Budget: Key HHS Proposals

On March 11, 2019, the White House released its FY 2020 budget proposal. In the area of health care, the president has requested $87.1 billion in discretionary budget authority for HHS, which represents a 12 percent decrease from the 2019 estimated level. Read on for key HHS proposal highlights.

ORIGINAL ANALYSIS

Load more
beakernav X1E2BFA62-BFCE-43C1-B777-27E3E5216018medical bagoriginal analysis +external linkpdf downloadstethoscope